InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,166.00
(
-0.05%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.47
(
0.34%
)
Bitcoin
60,874.64
(
-1.52%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: None

Friday, 02/25/2011 9:07:02 AM

Friday, February 25, 2011 9:07:02 AM

Post# of 92948
Thanks to louisa, the following changes/additions can be seen at the bottom of blog post from ACT site.
http://www.actcblog.com/2011/02/act-secures-patent-to-generate-embryonic-stem-cells-without-embryo-destruction.html

RUSSO PARTNERS: ACT is a client.
http://www.russopartnersllc.com/clients/

"From the biotechnology evolution to the launch of pharmaceutical marketing 2.0, we have been there every step of the way. At Russo Partners, formerly Noonan Russo, senior PR counselors with PhDs and MBAs roll up their sleeves - right alongside clients - to connect with and influence the audiences that matter most: investors, business partners, regulatory agencies, physicians and patients."
http://www.russopartnersllc.com/about/

Contact:
Investors:
CEOcast, Inc., James Young, 212-732-4300

Press:
ACT Corporate Communications, Bill Douglass, 646-450-3615
or:
Russo Partners, Martina Schwarzkopf, Ph.D., 212-845-4292

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up